Drug maker Elder Pharma has posted a rise of 40% in its consolidated revenues at Rs 251 crore for the December quarter versus Rs 180 crore in the same quarter a year ago. Despite this jump in sales, the company`s consolidated net profit was flat at Rs 15.8 crore for the December quarter versus Rs 15.4 crore.
In an exclusive interview with of Letha Venkatesh and Gautum Broker of CNBC TV18's Alok Saxena, Director, Elder Pharmaceuticals said, "The company is seeing strong growth due to consolidation of Neutrahealth. Also, it is confident of getting positive turnover from Bulgaria in the next financial year." "If you look at out standalone numbers you will see that there is much better position on the domestic front thatDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
